Aikchol Hospital Public (AHC) Fundamentals 2026 — P/E 16.4x, Revenue Analysis | SniperIQ
Aikchol Hospital Public (AHC) is a TH-listed Healthcare company in Medical - Care Facilities with a market capitalization of ฿2.1B, trading at ฿13.80 on the SET. This SniperIQ fundamentals page covers Aikchol Hospital Public's valuation (P/E 16.4x, P/B 1.0x), profitability (net margin 7.1%), revenue (฿1.8B in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Aikchol Hospital Public's market cap?
Aikchol Hospital Public (AHC) has a market capitalization of approximately ฿2.1B, trading at ฿13.80 on the SET. Market cap moves with the live share price.
What is Aikchol Hospital Public's P/E ratio?
Aikchol Hospital Public's trailing twelve-month P/E ratio is 16.4x, with a price-to-book (P/B) of 1.0x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Aikchol Hospital Public?
Aikchol Hospital Public runs a net profit margin of 7.1%, a gross margin of 19.8%, and an operating margin of 7.8%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Aikchol Hospital Public generate?
Aikchol Hospital Public reported revenue of ฿1.8B for fiscal year 2025, with net income of ฿154M and earnings per share (EPS) of 1.03. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Aikchol Hospital Public pay a dividend?
Aikchol Hospital Public offers a trailing dividend yield of about 3.8%. Dividend sustainability depends on payout ratio, free cash flow, and earnings stability — all tracked in SniperIQ's fundamentals view.
Is Aikchol Hospital Public financially healthy?
Aikchol Hospital Public carries a debt-to-equity ratio of 0.01x and a current ratio of 6.54x, with a market beta of 0.09. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Aikchol Hospital Public a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Aikchol Hospital Public (AHC) the key facts are: market cap ฿2.1B, P/E 16.4x, revenue ฿1.8B, 52-week range 11.7-16.2. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Aikchol Hospital Public's full fundamentals live
Get Aikchol Hospital Public's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.